Skip to main content
. 2015 Oct 30;30(6):865–872. doi: 10.3904/kjim.2015.30.6.865

Figure 3.

Figure 3.

Impact of combined acute rejection on allograft outcome after BK virus-associated nephropathy (BKVAN) diagnosis. (A) Comparison of the development of allograft failure based on combined acute rejection. (B) Comparison of allograft survival rates between patients with and without combined acute rejection using Kaplan-Meier analysis. (C) Comparison of acute rejection rates within 6 months from BKVAN diagnosis. Patients with combined acute rejection had a higher risk of allograft failure, lower allograft survival rates, and higher acute rejection rates within 6 months from BKVAN diagnosis than did those without combined acute rejection. ap < 0.05 vs. acute rejection (+).